Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Issues
2015
May 2015, Vol 6, No 4
May 2015, Vol 6, No 4
Two Immunotherapies Are Better Than One in Advanced Melanoma
By
Phoebe Starr
AACR Meeting Highlights
May 2015, Vol 6, No 4
Philadelphia, PA—Combination immunotherapy with ipilimumab (Yervoy) plus nivolumab (Opdivo) was superior to ipilimumab monotherapy in previously untreated patients with advanced melanoma in a phase 2 randomized clinical trial, according to lead investigator F. Stephen Hodi, MD, Director of the Melanoma Center, Dana-Farber Cancer Institute, Boston, MA, who presented the study at the 2015 American Association for Cancer Research (AACR) annual meeting.
Read Article
Value Propositions - May 2015
Economics & Value
,
Value Propositions
,
Value Peer-spectives
May 2015, Vol 6, No 4
Read Article
FDA News - May 2015
FDA Approvals, News & Updates
May 2015, Vol 6, No 4
Read Article
Value of Cancer Care for Most Tumors Lower in United States than in Western Europe
By
Rosemary Frei, MSc
Economics & Value
,
Economics of Cancer Care
May 2015, Vol 6, No 4
A reevaluation of the value of cancer care between 1982 and 2010 in the United States versus Western Europe (Soneji S, Yang JW. Health Aff [Millwood]. 2015;34:390-397) paints an entirely different picture from a similar analysis published in 2012 (Philipson T, et al. Health Aff [Millwood]. 2012;31:667-675). The earlier study found significant improvements in breast and prostate cancer survival in the United States relative to Western Europe, concluding that the high costs in the United States were worth it.
Read Article
Promising Therapies in Multiple Drug Classes Being Explored for B-Cell Lymphomas
By
Wayne Kuznar
NCCN 2015 Updates
May 2015, Vol 6, No 4
Hollywood, FL—Targeted therapy in B-cell lymphoma is rapidly expanding beyond anti-CD20 antibodies. Some of the emerging therapies are conjugated antibodies, treatments that target signaling pathways or apoptosis, immunomodulatory drugs (IMiDs), and immune checkpoint inhibitors, said Andrew D. Zelenetz, MD, PhD, Vice Chair, Medical Informatics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, at the 2015 National Comprehensive Cancer Network conference.
Read Article
Pembrolizumab Scores Big Over Ipilimumab in Advanced Melanoma
By
Phoebe Starr
AACR Meeting Highlights
May 2015, Vol 6, No 4
Philadelphia, PA—As new immunotherapies become available for the treatment of melanoma and other cancers, head-to-head trials of these agents shed more light on how best to use them. In the phase 3 KEYNOTE-006 trial, pembrolizumab (Keytruda) outperformed ipilimumab (Yervoy)—a current standard of care—as upfront treatment for patients with unresectable advanced melanoma. The data were presented at the 2015 American Association for Cancer Research annual meeting.
Read Article
AVBCC 5th Conference: Continuing Challenges for Optimizing Value in Oncology
By
Wayne Kuznar
May 2015, Vol 6, No 4
Washington, DC—The Fifth Annual Conference of the Association for Value-Based Cancer Care (AVBCC), held May 3-6, 2015, launched 3 days of presentations by US oncology stakeholders, including physicians, pharmacists, nurses, payers, policymakers, and drug/diagnostics manufacturers.
Read Article
Page 3 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma